PCRX vs. MPAA

Last updated Jun 4, 2026

PCRX (Pacira BioSciences, Inc.) and MPAA (Motorcar Parts of America, Inc.) are both stocks. PCRX operates in Drug Manufacturers - Specialty & Generic (Healthcare), while MPAA operates in Auto Parts (Consumer Cyclical). Over the past 10 years, PCRX returned -7.19%/yr vs -9.63%/yr for MPAA. At a 0.20 correlation, their price movements are largely independent.

Performance

PCRX vs. MPAA - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Pacira BioSciences, Inc. (PCRX) and Motorcar Parts of America, Inc. (MPAA). The values are adjusted to include any dividend payments, if applicable.

Returns By Period

In the year-to-date period, PCRX achieves a -13.76% return, which is significantly higher than MPAA's -14.51% return. Over the past 10 years, PCRX has outperformed MPAA with an annualized return of -7.19%, while MPAA has yielded a comparatively lower -9.63% annualized return.

PCRX

• 1D: 0.31%
• 1M: -9.60%
• YTD: -13.76%
• 6M: -7.73%
• 1Y: -15.45%
• 3Y*: -17.04%
• 5Y*: -18.20%
• 10Y*: -7.19%

MPAA

• 1D: -1.49%
• 1M: -5.25%
• YTD: -14.51%
• 6M: -19.59%
• 1Y: -11.34%
• 3Y*: 23.43%
• 5Y*: -15.27%
• 10Y*: -9.63%

*Multi-year figures are annualized to reflect compound growth (CAGR)

PCRX vs. MPAA - Yearly Performance Comparison

	2026 (YTD)	2025	2024	2023	2022	2021	2020	2019	2018	2017
PCRX Pacira BioSciences, Inc.	-13.76%	37.37%	-44.16%	-12.61%	-35.83%	0.55%	32.10%	5.30%	-5.76%	41.33%
MPAA Motorcar Parts of America, Inc.	-14.51%	62.37%	-18.63%	-21.25%	-30.52%	-13.00%	-10.94%	32.39%	-33.41%	-7.17%

Correlation

The correlation between PCRX and MPAA is 0.19, which is low. Their price movements are largely independent, making them effective diversification partners.

	Correlation
Correlation (1Y) Calculated over the trailing 1-year period	0.19
Correlation (3Y) Calculated over the trailing 3-year period	0.15
Correlation (5Y) Calculated over the trailing 5-year period	0.16
Correlation (10Y) Calculated over the trailing 10-year period	0.20
Correlation (All Time) Calculated using the full available price history since Feb 4, 2011	0.20

Fundamentals

Market Cap PCRX : $913.11M MPAA : $212.54M
EPS PCRX : $0.21 MPAA : $0.10
PE Ratio PCRX : 104.26 MPAA : 107.29
PS Ratio PCRX : 1.32 MPAA : 0.27
PB Ratio PCRX : 1.40 MPAA : 0.82
Total Revenue (TTM) PCRX : $734.86M MPAA : $770.64M
Gross Profit (TTM) PCRX : $427.72M MPAA : $148.02M
EBITDA (TTM) PCRX : $95.04M MPAA : $60.93M

Return for Risk

PCRX vs. MPAA — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

PCRX

PCRX Risk / Return Rank: 22
PCRX Sharpe Ratio Rank: 23
PCRX Sortino Ratio Rank: 23
PCRX Omega Ratio Rank: 23
PCRX Calmar Ratio Rank: 23
PCRX Martin Ratio Rank: 19

MPAA

MPAA Risk / Return Rank: 34
MPAA Sharpe Ratio Rank: 33
MPAA Sortino Ratio Rank: 34
MPAA Omega Ratio Rank: 34
MPAA Calmar Ratio Rank: 33
MPAA Martin Ratio Rank: 33

The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

PCRX vs. MPAA - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Pacira BioSciences, Inc. (PCRX) and Motorcar Parts of America, Inc. (MPAA). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

	PCRX	MPAA	Difference
Sharpe ratio Return per unit of total volatility	-0.42	-0.19	-0.23
Sortino ratio Return per unit of downside risk	-0.36	0.16	-0.53
Omega ratio Gain probability vs. loss probability	0.96	1.02	-0.07
Calmar ratio Return relative to maximum drawdown	-0.52	-0.25	-0.28
Martin ratio Return relative to average drawdown	-1.07	-0.43	-0.64
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month.

PCRX vs. MPAA - Sharpe Ratio Comparison

The current PCRX Sharpe Ratio is -0.42, which is lower than the MPAA Sharpe Ratio of -0.19. The chart below compares the historical Sharpe Ratios of PCRX and MPAA, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.

Sharpe Ratios by Period

	PCRX	MPAA	Difference
Sharpe Ratio (1Y) Calculated over the trailing 1-year period	-0.42	-0.19	-0.23
Sharpe Ratio (5Y) Calculated over the trailing 5-year period	-0.40	-0.25	-0.15
Sharpe Ratio (10Y) Calculated over the trailing 10-year period	-0.15	-0.18	+0.02
Sharpe Ratio (All Time) Calculated using the full available price history	0.16	0.01	+0.14

Drawdowns

PCRX vs. MPAA - Drawdown Comparison

The maximum PCRX drawdown since its inception was -90.19%, smaller than the maximum MPAA drawdown of -97.82%. Use the drawdown chart below to compare losses from any high point for PCRX and MPAA.

Drawdown Indicators

	PCRX	MPAA	Difference
Max Drawdown Largest peak-to-trough decline	-90.19%	-97.82%	+7.63%
Max Drawdown (1Y) Largest decline over 1 year	-29.61%	-46.31%	+16.70%
Max Drawdown (3Y) Largest decline over 3 years	-71.53%	-53.34%	-18.19%
Max Drawdown (5Y) Largest decline over 5 years	-85.67%	-82.71%	-2.96%
Max Drawdown (10Y) Largest decline over 10 years	-85.67%	-86.63%	+0.96%
Current Drawdown Current decline from peak	-81.29%	-73.79%	-7.50%
Average Drawdown Average peak-to-trough decline	-50.01%	-51.31%	+1.30%
Ulcer Index Depth and duration of drawdowns from previous peaks	14.42%	26.20%	-11.78%

Volatility

PCRX vs. MPAA - Volatility Comparison

Pacira BioSciences, Inc. (PCRX) and Motorcar Parts of America, Inc. (MPAA) have volatilities of 10.03% and 9.86%, respectively, indicating that both stocks experience similar levels of price fluctuations. This suggests that the risk associated with both stocks, as measured by volatility, is nearly the same. The chart below showcases a comparison of their rolling one-month volatility.

Volatility by Period

	PCRX	MPAA	Difference
Volatility (1M) Calculated over the trailing 1-month period	10.03%	9.86%	+0.17%
Volatility (6M) Calculated over the trailing 6-month period	28.70%	33.37%	-4.67%
Volatility (1Y) Calculated over the trailing 1-year period	37.03%	61.52%	-24.49%
Volatility (5Y) Calculated over the trailing 5-year period, annualized	45.60%	60.98%	-15.38%
Volatility (10Y) Calculated over the trailing 10-year period, annualized	46.90%	54.45%	-7.55%

Dividends

PCRX vs. MPAA - Dividend Comparison

Neither PCRX nor MPAA has paid dividends to shareholders.

Tickers have no history of dividend payments

Financials

PCRX vs. MPAA - Profitability Comparison

The chart below illustrates the profitability comparison between Pacira BioSciences, Inc. and Motorcar Parts of America, Inc. over time, highlighting three key metrics: Gross Profit Margin, Operating Margin, and Net Profit Margin.

PCRX - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Pacira BioSciences, Inc. reported a gross profit of 0.00 and revenue of 177.38M. Therefore, the gross margin over that period was 0.0%.

MPAA - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Motorcar Parts of America, Inc. reported a gross profit of 32.88M and revenue of 167.70M. Therefore, the gross margin over that period was 19.6%.

PCRX - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Pacira BioSciences, Inc. reported an operating income of 6.90M and revenue of 177.38M, resulting in an operating margin of 3.9%.

MPAA - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Motorcar Parts of America, Inc. reported an operating income of 8.33M and revenue of 167.70M, resulting in an operating margin of 5.0%.

PCRX - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Pacira BioSciences, Inc. reported a net income of 7.08M and revenue of 177.38M, resulting in a net margin of 4.0%.

MPAA - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Motorcar Parts of America, Inc. reported a net income of 1.78M and revenue of 167.70M, resulting in a net margin of 1.1%.

Frequently Asked Questions

Can I hold both PCRX and MPAA in my portfolio?

PCRX and MPAA have a correlation of 0.19, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

Which is riskier, PCRX or MPAA?

PCRX has higher volatility (10.03%) compared to MPAA (9.86%). In terms of maximum drawdown, PCRX dropped -90.19% vs MPAA's -97.82%.

Which has better risk-adjusted returns?

MPAA currently has the higher Sharpe Ratio (-0.19 vs -0.42), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.